DRI Healthcare Trust (TSE:DHT.UN) to Issue Quarterly Dividend of $0.11

Posted by Stanley Muller on Jun 28th, 2026

DRI Healthcare Trust (TSE:DHT.UN – Get Free Report) announced a quarterly dividend on Tuesday, June 30th, TickerTech Dividends reports. Shareholders of record on Monday, July 20th will be paid a dividend of 0.11 per share on Monday, July 20th. This represents a c) annualized dividend and a yield of 2.5%. The ex-dividend date is Tuesday, June 30th.

DRI Healthcare Trust Price Performance

Shares of DHT.UN stock opened at C$17.45 on Friday. DRI Healthcare Trust has a 1 year low of C$13.20 and a 1 year high of C$19.04. The stock’s 50 day simple moving average is C$17.13 and its two-hundred day simple moving average is C$16.62. The company has a market cap of C$960.03 million, a PE ratio of -19.39 and a beta of 0.47.

Analysts Set New Price Targets

Several research firms have recently weighed in on DHT.UN. Stifel Nicolaus boosted their target price on DRI Healthcare Trust from C$22.00 to C$23.00 and gave the company a “buy” rating in a research report on Tuesday, May 19th. Scotiabank raised their price target on DRI Healthcare Trust from C$25.00 to C$30.00 and gave the stock a “sector outperform” rating in a research report on Tuesday, May 19th. Finally, National Bank Financial lifted their price objective on shares of DRI Healthcare Trust from C$22.50 to C$23.50 and gave the stock an “outperform” rating in a research note on Tuesday, May 19th. Three investment analysts have rated the stock with a Buy rating, Based on data from MarketBeat, DRI Healthcare Trust currently has an average rating of “Buy” and a consensus target price of C$25.50.

Check Out Our Latest Stock Analysis on DRI Healthcare Trust

DRI Healthcare Trust Company Profile

(Get Free Report)

DRI Healthcare Trust is managed by DRI Capital Inc DRI a pioneer in global pharmaceutical royalty monetization. We provide uniquely favorable exposure for investors in the biopharma industry managing a diversified portfolio of interests in medicines that have a demonstrable positive impact on the world and aiming to acquire dependable patent-protected cash flow streams derived from the sales of those important drugs while limiting the risks and costs connected to drug development. DRI has developed a disciplined strategy predicated on actively sourcing royalty streams on medically necessary products and proudly work with multiple repeat deal partners.DRI Healthcare Trust is an unincorporated open-ended trust governed by the laws of the Province of Ontario pursuant to a declaration of trust dated October 21 2020 as amended.DRI Healthcare Trusts units are listed and trade on the Toronto Stock Exchange under DHT.UN in Canadian dollars and under DHT.U in U.S.